News
IDXX
646.53
+1.05%
6.74
IDEXX Labs Is Maintained at Neutral by Piper Sandler
Dow Jones · 1d ago
IDEXX Labs Price Target Cut to $750.00/Share From $775.00 by Piper Sandler
Dow Jones · 1d ago
Piper Sandler Maintains Neutral on IDEXX Laboratories, Lowers Price Target to $750
Benzinga · 1d ago
Idexx Laboratories price target lowered to $750 from $775 at Piper Sandler
TipRanks · 1d ago
Weekly Report: what happened at IDXX last week (0202-0206)?
Weekly Report · 1d ago
Is IDEXX’s Innovation-Fueled 2025 Results And 2026 Outlook Altering The Investment Case For IDXX?
Simply Wall St · 4d ago
4 Analysts Have This To Say About IDEXX Laboratories
Benzinga · 5d ago
IDEXX Labs Is Maintained at Overweight by Barclays
Dow Jones · 5d ago
IDEXX Labs Price Target Cut to $800.00/Share From $850.00 by Barclays
Dow Jones · 5d ago
Barclays Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $800
Benzinga · 5d ago
IDEXX LABORATORIES, INC. <IDXX.O>: BARCLAYS CUTS TARGET PRICE TO $800 FROM $850
Reuters · 5d ago
Idexx Laboratories price target lowered to $800 from $850 at Barclays
TipRanks · 5d ago
U.S. RESEARCH ROUNDUP-Alphabet, Corteva, Varonis Systems
Reuters · 5d ago
Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX), Qiagen (QGEN) and InnovAge Holding (INNV)
TipRanks · 5d ago
Piper Sandler Appoints Stuart Essig to Board of Directors
Reuters · 6d ago
Assessing IDEXX Laboratories (IDXX) Valuation After Strong 2025 Earnings Beat And 2026 Growth Guidance
Simply Wall St · 6d ago
IDEXX: A Great Business Trapped By A Demanding Valuation
Seeking Alpha · 6d ago
IDEXX LABORATORIES INC <IDXX.O>: UBS CUTS TARGET PRICE TO $730 FROM $750
Reuters · 02/03 15:24
IDEXX Laboratories Analysts Cut Their Forecasts Following Q4 Results
Benzinga · 02/03 15:12
IDEXX Labs Is Maintained at Neutral by UBS
Dow Jones · 02/03 14:38
More
Webull provides a variety of real-time IDXX stock news. You can receive the latest news about IDEXX Laboratories through multiple platforms. This information may help you make smarter investment decisions.
About IDXX
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.